Granotapide (JTT-130) is an orally active microsomal triglyceride transfer protein (MTP) inhibitor. Granotapide reduces absorption of cholesterol and triglycerides through inhibition of MTP. Granotapide can be used for the research of dyslipidemia[1].
Molecular Weight:
718.71
CAS Number:
[594842-13-4]
Formula:
C39H37F3N2O8
Target:
Microsomal Triglyceride Transfer Protein (MTP)
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted